A randomized, double-blind, phase 2 study evaluating the safety and efficacy of AMG 416 for the treatment of secondary hyperparathyroidism in hemodialysis patients. [electronic resource]
Producer: 20151013Description: 943-52 p. digitalISSN:- 1473-4877
- Adult
- Aged
- Double-Blind Method
- Female
- Humans
- Hyperparathyroidism, Secondary -- drug therapy
- Injections, Intravenous
- Male
- Middle Aged
- Parathyroid Hormone -- blood
- Peptides -- administration & dosage
- Receptors, Calcium-Sensing -- agonists
- Renal Dialysis -- adverse effects
- Renal Insufficiency, Chronic -- complications
No physical items for this record
Publication Type: Clinical Trial, Phase II; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.